JPS6434925A - Method for cultivating bordetella pertussis, pertussis toxoid and mixed vaccine thereof - Google Patents
Method for cultivating bordetella pertussis, pertussis toxoid and mixed vaccine thereofInfo
- Publication number
- JPS6434925A JPS6434925A JP63103405A JP10340588A JPS6434925A JP S6434925 A JPS6434925 A JP S6434925A JP 63103405 A JP63103405 A JP 63103405A JP 10340588 A JP10340588 A JP 10340588A JP S6434925 A JPS6434925 A JP S6434925A
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- pertussis
- bordetella pertussis
- derivative
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PURPOSE:To obtain a high-purity pertussis toxin (PT) and fibrous hemagglutinin (F-HA) in high yield at an extremely low cost, by cultivating Bordetella pertussis in a culture medium containing cellulose (derivative). CONSTITUTION:Cellulose or a derivative thereof or both are added and blended with a basal culture medium (e.g. Cohen.Wheeler culture medium) used for cultivating Bordetella pertussis so as to provide 0.01-2.0wt.% final concentration and the Bordetella pertussis is cultivated in the resultant modified culture medium at 30-37 deg.C for 20-80hr. The obtained culture is subsequently separated into a cultivation supernatant and microbial cells. The above-mentioned cultivation supernatant is then purified to recover PT and F-HA. Formalin is subsequently added and mixed to detoxify the purified PT and F-HA fraction and formalin is removed by dialysis. The resultant dialyzate is diluted with a phosphoric acid buffer solution, etc., to provide a vaccine concentrate, which is then used to prepare a mixed vaccine. Gelatin (derivative) in an amount of 0.1-5.0wt.% as a stabilizer is added to remarkably improve heat and cold resistance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63103405A JP2743177B2 (en) | 1987-04-24 | 1988-04-25 | Method of culturing pertussis, pertussis toxoid and combination vaccine thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10236087 | 1987-04-24 | ||
JP62-102360 | 1987-04-24 | ||
JP63103405A JP2743177B2 (en) | 1987-04-24 | 1988-04-25 | Method of culturing pertussis, pertussis toxoid and combination vaccine thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6434925A true JPS6434925A (en) | 1989-02-06 |
JP2743177B2 JP2743177B2 (en) | 1998-04-22 |
Family
ID=26443067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63103405A Expired - Fee Related JP2743177B2 (en) | 1987-04-24 | 1988-04-25 | Method of culturing pertussis, pertussis toxoid and combination vaccine thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2743177B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002005846A1 (en) * | 2000-07-05 | 2002-01-24 | Green Cross Vaccine Co., Ltd. | Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen, and preparation method thereof |
JP2002523470A (en) * | 1998-09-01 | 2002-07-30 | エラン コーポレーシヨン ピーエルシー | Oral vaccine composition |
JP2011242408A (en) * | 2011-08-04 | 2011-12-01 | Collagen Gijutsu Kenshukai Kk | Method of measuring anti-gelatin antibody |
JP2015529462A (en) * | 2012-08-30 | 2015-10-08 | メリアル インコーポレイテッド | High pressure devices and methods for making inactivated vaccines and for refolding / solubilizing recombinant proteins |
CN111855827A (en) * | 2019-04-24 | 2020-10-30 | 岛津企业管理(中国)有限公司 | Method for determining polysaccharide protein binding site binding rate in polysaccharide protein binding vaccine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62253377A (en) * | 1986-03-27 | 1987-11-05 | パスツール メリウー セロム エ ヴアクサン | Medium and method for culture of bordetella bacteria |
-
1988
- 1988-04-25 JP JP63103405A patent/JP2743177B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62253377A (en) * | 1986-03-27 | 1987-11-05 | パスツール メリウー セロム エ ヴアクサン | Medium and method for culture of bordetella bacteria |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002523470A (en) * | 1998-09-01 | 2002-07-30 | エラン コーポレーシヨン ピーエルシー | Oral vaccine composition |
WO2002005846A1 (en) * | 2000-07-05 | 2002-01-24 | Green Cross Vaccine Co., Ltd. | Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen, and preparation method thereof |
JP2011242408A (en) * | 2011-08-04 | 2011-12-01 | Collagen Gijutsu Kenshukai Kk | Method of measuring anti-gelatin antibody |
JP2015529462A (en) * | 2012-08-30 | 2015-10-08 | メリアル インコーポレイテッド | High pressure devices and methods for making inactivated vaccines and for refolding / solubilizing recombinant proteins |
CN111855827A (en) * | 2019-04-24 | 2020-10-30 | 岛津企业管理(中国)有限公司 | Method for determining polysaccharide protein binding site binding rate in polysaccharide protein binding vaccine |
CN111855827B (en) * | 2019-04-24 | 2022-09-16 | 岛津企业管理(中国)有限公司 | Method for determining polysaccharide protein binding site binding rate in polysaccharide protein binding vaccine |
Also Published As
Publication number | Publication date |
---|---|
JP2743177B2 (en) | 1998-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8505818A1 (en) | Method for the production of HA fraction containing protective antigens of Bordetella pertussis and pertussis vaccine. | |
JP2549225B2 (en) | Method for purifying pertussis outer membrane protein | |
ATE399855T1 (en) | ANIMAL CELL CULTURE MEDIUM WITH PLANT NUTRIENTS | |
ATE331731T1 (en) | METHOD FOR PRODUCING DIPHTHERIA TOXIN | |
EP0067697B1 (en) | Cell culture method | |
GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
ATE268384T1 (en) | ANALOGUE OF HAEMOPHILUS HIN47 WITH REDUCED PROTEASE ACTIVITY | |
JPS6434925A (en) | Method for cultivating bordetella pertussis, pertussis toxoid and mixed vaccine thereof | |
Eagle | Relative Growth-Promoting Activity in Tissue Culture of Go-Factors and the Parent Vitamins | |
JPS6211090A (en) | Toreponema hyodicenteriae bacterin and its method | |
DE69325449D1 (en) | METHOD FOR DEVELOPING NEW PLANT TYPES WITH CAPACITY FOR BONDING NITROGEN ALSO IN THE LEAVES | |
Porter et al. | The nutrition of Staphylococcus aureus: The influence of biotin, bios IIB and vitamin H on the growth of several strains | |
US3594284A (en) | Lysostaphin fermentation with accelerated time cycle | |
Vasil et al. | Temperature-dependent inactivating factor of Pseudomonas aeruginosa exotoxin A | |
CN1617882B (en) | Method of isolation and purification of trypsin from pronase protease and use thereof | |
Stalheim | Leptospiral selection, growth, and virulence in synthetic medium | |
DE1941768C3 (en) | Method of making uricase | |
JPS5688799A (en) | Preparation of l-lysine | |
JPS5675097A (en) | Thermophilic aspartase and its preparation | |
DE2845745C2 (en) | ||
JPS6456620A (en) | Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen | |
GB1274820A (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
JPS62163681A (en) | Culture of babesia canis production of antigen and vaccine applying said culture method and antigen and vaccine for piroplasma | |
JPS6181786A (en) | Production of n-acylneuraminic acid aldolase | |
JPS56125397A (en) | Oligosaccharide derivative, its preparation and preventing agent against decayed tooth containing the same as active constituent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |